Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Mr. Lichti is, as of the date of this Amendment No. 1 to Schedule 13G ("Amendment No. 1"), the Manager of Northstrive Fund II LP. As of December 9, 2025, (please refer to Item 4 of this Amendment No. 1, below, for additional detail in relation to this date), the Reporting Person(s) are no longer beneficial owners or no longer deemed to be beneficial owners of any shares of Common Stock of Enveric Biosciences, Inc. (the "Issuer").


SCHEDULE 13G




Comment for Type of Reporting Person:  Mr. Lichti is, as of the date of this Amendment No.1, the Manager of Northstrive Fund II LP. As of December 9, 2025, (please refer to Item 4 of this Amendment No. 1, below, for additional detail in relation to this date), the Reporting Person(s) are no longer beneficial owners or no longer deemed to be beneficial owners of any shares of Common Stock of the Issuer.


SCHEDULE 13G



 
Braeden Lichti
 
Signature:/s/ Braeden Lichti
Name/Title:Braeden Lichti
Date:12/10/2025
 
Northstrive Fund II LP
 
Signature:/s/ Braeden Lichti
Name/Title:Braeden Lichti, Manager
Date:12/10/2025